Luye Pharma plans USD-denominated convertible bond issue alongside repurchase of US$ 180 million 6.25% convertibles due 2028

  • Luye Pharma launched a proposed issue of USD-denominated convertible bonds to institutional investors, alongside a repurchase of its US$ 180 million 6.25% convertible bonds due 2028.
  • UBS AG Hong Kong Branch was appointed to coordinate pricing for the new convertible bond issue.
  • Net proceeds are intended to refinance existing debt, including funding the concurrent repurchase, with remaining funds for general corporate purposes.
  • The buyback process began with a dealer manager agreement signed on June 3, 2026 to solicit bondholder selling interest.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Luye Pharma Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260603-12187990), on June 03, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.